#Germany #Munich #NovaSeq X #Sequencing #Novogene

Novogene Europe Expands Sequencing Capacity

In a significant move to cater to the growing demand for high-throughput sequencing in Europe, Novogene Europe has officially announced the installation of its fifth Illumina NovaSeq X Plus sequencing system. This strategic expansion reinforces Novogene's reputation as one of Europe’s leading sequencing service providers, renowned for delivering high-speed results, exceptional data quality, and scalability in research applications.

Meeting the Rising Demand

Tingting Zhou, Vice President of Novogene Europe, stated, "Our investment in the NovaSeq X Plus allows us to adequately meet our customers' rising expectations regarding turnaround times and data quality. This enhancement ensures we continue to drive innovations in sequencing services and aid researchers in achieving scientific breakthroughs."

The NovaSeq X Plus platform symbolizes cutting-edge technology in sequencing, capable of generating an impressive 16 terabases of data within just 48 hours. This capability makes it instrumental for pivotal applications such as whole-genome sequencing, single-cell RNA sequencing, and comprehensive population studies.

Advancing Research and Technology

The latest expansion is crucial as researchers face increasingly complex genomic questions requiring high data throughput alongside robust quality metrics. The addition of a new NovaSeq X Plus at Novogene Europe’s laboratories assures clients that they can successfully tackle demanding projects.

Utilizing state-of-the-art technology, Novogene is positioned to deliver faster results without sacrificing data integrity or environmental responsibility. Bas Verhoef, Senior Vice President and Regional Head of Europe at Illumina, emphasized the long-standing partnership between Illumina and Novogene, stating, “For over a decade, we have closely collaborated to advance genomic research. The NovaSeq X Plus— the fastest adopted high-throughput sequencing platform by Illumina—ensures researchers gain access to top-tier technologies providing reliable, swift, and cost-effective sequencing services.”

A Step Forward for Genomic Science

In recent years, Novogene Europe has consistently integrated leading-edge technologies into its service portfolio, offering genome, transcriptome, microorganism, and single-cell sequencing. With local deployment within European laboratories, tailored solutions can be provided while adhering to global quality standards.

Novogene's vision is to maintain its position as a global leader in genomic research services, leveraging its substantial sequencing capacity. Equipped with extensive scientific expertise and premier customer service, Novogene is committed to supporting clients in realizing their research goals in the rapidly evolving landscape of genomics.

In conclusion, the inauguration of the fifth NovaSeq X Plus system marks a pivotal point in Novogene Europe’s journey, enhancing its capabilities and further solidifying its status as a dependable partner for sequencing solutions in Europe.

For more information about Novogene and its pioneering sequencing services, contact: Novogene Europe.